SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001654954-21-008334
Filing Date
2021-07-29
Accepted
2021-07-29 17:13:05
Documents
12
Period of Report
2021-09-17

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT vtgndef14a_072021.htm DEF 14A 1105081
2 IMAGE cover2000.jpg GRAPHIC 37805
3 IMAGE cunningham.jpg GRAPHIC 4704
4 IMAGE curley.jpg GRAPHIC 4678
5 IMAGE fitzpatrick.jpg GRAPHIC 6846
6 IMAGE gin.jpg GRAPHIC 4445
7 IMAGE proxycard000.jpg GRAPHIC 72682
8 IMAGE proxycard001.jpg GRAPHIC 56551
9 IMAGE rotunno.jpg GRAPHIC 6258
10 IMAGE saxe.jpg GRAPHIC 3547
11 IMAGE singh3.jpg GRAPHIC 9156
12 IMAGE vistagen.jpg GRAPHIC 5672
  Complete submission text file 0001654954-21-008334.txt   1400074
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: DEF 14A | Act: 34 | File No.: 001-37761 | Film No.: 211128539
SIC: 2834 Pharmaceutical Preparations